Study of Sulfasalazine in Treating Painful Neuropathy

Clinical Trial Summary

The investigators hypothesize that sulfasalazine, an FDA-approved medication for rheumatoid arthritis and ulcerative colitis, may be beneficial in neuropathic pain conditions. In this study, the investigators will evaluate whether sulfasalazine improves pain due to painful peripheral neuropathy.

See also
Status	Clinical Trial	Phase
Completed	`NCT02125006` - The Effect of an Inter-Disciplinary Program, Including MBSR, in Breast Cancer Survivors With Chronic Neuropathic Pain	N/A
Completed	`NCT01363284` - Pretreatment Identification of Duloxetine Success in Neuropathic Pain Patients	N/A
Completed	`NCT02758197` - Online MBSR Program for Cancer Survivors With Chronic Neuropathic Pain	N/A
Withdrawn	`NCT01992562` - Single Shot Intrathecal Ziconotide for Painful Neuropathy or Myelopathy	Phase 4

See also

Status

Clinical Trial

Phase

Completed

NCT02125006 - The Effect of an Inter-Disciplinary Program, Including MBSR, in Breast Cancer Survivors With Chronic Neuropathic Pain

N/A

Completed

NCT01363284 - Pretreatment Identification of Duloxetine Success in Neuropathic Pain Patients

N/A

Completed

NCT02758197 - Online MBSR Program for Cancer Survivors With Chronic Neuropathic Pain

N/A

Withdrawn

NCT01992562 - Single Shot Intrathecal Ziconotide for Painful Neuropathy or Myelopathy

Phase 4

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT01667029
Study type	Interventional
Source	Massachusetts General Hospital
Contact
Status	Terminated
Phase	Phase 2
Start date	May 2013
Completion date	August 10, 2017

Study of Sulfasalazine in Treating Painful Neuropathy

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms